Hepatocyte growth factor receptor
Hepatocyte growth factor receptor
The Hepatocyte growth factor receptor (HGFR), also known as c-Met, is a protein encoded by the MET gene in humans. This receptor is a member of the receptor tyrosine kinase family and plays a crucial role in various cellular processes, including cell growth, cell motility, morphogenesis, and angiogenesis.
Structure
The c-Met receptor is a single-pass transmembrane protein composed of an extracellular ligand-binding domain, a transmembrane domain, and an intracellular tyrosine kinase domain. The extracellular domain is responsible for binding to its ligand, hepatocyte growth factor (HGF), also known as scatter factor (SF).
Function
Upon binding to HGF, c-Met undergoes dimerization and autophosphorylation on specific tyrosine residues within its intracellular domain. This activation triggers a cascade of downstream signaling pathways, including the PI3K/AKT pathway, RAS/MAPK pathway, and STAT pathway, which are involved in regulating cell proliferation, survival, and migration.
Clinical Significance
Aberrant activation of c-Met has been implicated in various cancers, including lung cancer, breast cancer, colorectal cancer, and gastric cancer. Overexpression, gene amplification, and mutations in the MET gene can lead to uncontrolled cell growth and metastasis. As a result, c-Met is considered a potential target for cancer therapy, and several c-Met inhibitors are currently being investigated in clinical trials.
Research and Therapeutic Development
Research on c-Met has led to the development of various therapeutic agents, including small molecule inhibitors, monoclonal antibodies, and HGF antagonists. These agents aim to block the HGF/c-Met signaling pathway and inhibit tumor growth and metastasis.
Related Pages
- Receptor tyrosine kinase
- Hepatocyte growth factor
- PI3K/AKT pathway
- RAS/MAPK pathway
- STAT pathway
- Cancer
- Lung cancer
- Breast cancer
- Colorectal cancer
- Gastric cancer
See Also
References
<references group="" responsive="1"></references>
External Links
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
